Zacks Investment Research downgraded shares of MedEquities Realty Trust (NYSE:MRT) from a buy rating to a hold rating in a research note released on Wednesday.

According to Zacks, “MedEquities Realty Trust, Inc. owns, develops, operates, leases and disposes healthcare properties and portfolios. It operates primarily in Texas, California, Nevada and South Carolina. MedEquities Realty Trust, Inc. is based in Nashville, Tennessee. “

A number of other brokerages have also recently commented on MRT. B. Riley reaffirmed a buy rating on shares of MedEquities Realty Trust in a research report on Wednesday, November 1st. Capital One Financial began coverage on MedEquities Realty Trust in a research report on Monday, October 23rd. They set an equal weight rating and a $13.00 price target for the company. KeyCorp set a $13.00 price target on MedEquities Realty Trust and gave the stock a buy rating in a research report on Sunday, October 29th. Finally, ValuEngine raised MedEquities Realty Trust from a hold rating to a buy rating in a research report on Friday, December 1st. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average price target of $13.00.

Shares of MedEquities Realty Trust (MRT) traded down $0.02 on Wednesday, reaching $11.19. The company’s stock had a trading volume of 107,500 shares, compared to its average volume of 345,538. MedEquities Realty Trust has a 12 month low of $10.06 and a 12 month high of $13.06. The firm has a market cap of $355.35, a PE ratio of 10.17 and a beta of -0.74.

In related news, CEO John W. Mcroberts acquired 18,000 shares of MedEquities Realty Trust stock in a transaction on Friday, November 17th. The stock was acquired at an average price of $10.74 per share, for a total transaction of $193,320.00. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Randy L. Churchey acquired 5,300 shares of MedEquities Realty Trust stock in a transaction on Monday, November 20th. The shares were bought at an average price of $10.87 per share, with a total value of $57,611.00. Following the purchase, the director now directly owns 46,776 shares in the company, valued at approximately $508,455.12. The disclosure for this purchase can be found here. Insiders have acquired a total of 23,600 shares of company stock valued at $254,129 in the last quarter. Company insiders own 2.50% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Prudential Financial Inc. raised its stake in shares of MedEquities Realty Trust by 5.4% during the 3rd quarter. Prudential Financial Inc. now owns 2,658,837 shares of the financial services provider’s stock valued at $31,242,000 after buying an additional 136,499 shares during the last quarter. American Century Companies Inc. raised its stake in shares of MedEquities Realty Trust by 11.2% during the 3rd quarter. American Century Companies Inc. now owns 1,726,208 shares of the financial services provider’s stock valued at $20,283,000 after buying an additional 174,261 shares during the last quarter. Boston Partners raised its stake in shares of MedEquities Realty Trust by 5.1% during the 3rd quarter. Boston Partners now owns 1,496,199 shares of the financial services provider’s stock valued at $17,581,000 after buying an additional 72,270 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of MedEquities Realty Trust by 5.9% during the 2nd quarter. Vanguard Group Inc. now owns 1,160,107 shares of the financial services provider’s stock valued at $14,640,000 after buying an additional 64,766 shares during the last quarter. Finally, State Street Corp raised its stake in shares of MedEquities Realty Trust by 41.7% during the 2nd quarter. State Street Corp now owns 529,702 shares of the financial services provider’s stock valued at $6,684,000 after buying an additional 155,934 shares during the last quarter. Institutional investors and hedge funds own 93.19% of the company’s stock.

TRADEMARK VIOLATION WARNING: This news story was published by Watch List News and is owned by of Watch List News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at https://www.watchlistnews.com/zacks-investment-research-lowers-medequities-realty-trust-mrt-to-hold/1798109.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with Analyst Ratings Network's FREE daily email newsletter.